Open API launched by myTomorrows
myTomorrows, global online facilitator of early access to investigational drugs, has introduced an openly accessible API to open up its comprehensive database of uniform information relating to clinical trials. Data on over 300,000 clinical trials, already accessible via its patient and physician centric website, can now be used by other organisations in their own environments. “Opening the myTomorrows database is a big push forward to make comprehensive and uniform information on clinical trials freely accessible to anybody who needs it. We hope to see further applications grow out of our data to better serve unmet medical needs globally and advance drug development” COO Robert Kraal explains, setting out myTomorrows’ hopes for the development. The interface can be used to search, filter, and download complete historic clinical trial records data accumulated from all the registries of the World Health Organization’s Primary Registry Network of medical trial registration partners. Potential applications include anything from ad-hoc queries by data scientists to patient trial screening to mobile health. “We have built the API with the intention of making it accessible for the largest group of stakeholders. Using a very simple approach, any programmer can directly access the data in a friendly human-readable format and structure” says Sander Nagtegaal, Chief Technical Officer at myTomorrows. For technical details, please visit the official documentation, the API terms of service or reach out to tech@mytomorrows.com directly.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
